M&T Bank
ANIK icon

M&T Bank’s Anika Therapeutics ANIK Stock Holding History

M&T Bank’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,903
Closed -$228K – 1819
2015
Q2 		$228K Hold
6,903
– – ﹤0.01% 1681
2015
Q1 		$284K Sell
6,903
-275
-4% -$11.1K ﹤0.01% 1486
2014
Q4 		$293K Sell
7,178
-442
-6% -$17.3K ﹤0.01% 1505
2014
Q3 		$280K Buy
+7,620
New +$329K ﹤0.01% 1616

Other funds holding ANIK

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
LCP
Lombardia Capital Partners Pasadena, California $110M AUM 13.11% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

M&T Bank's ANIK Position: Q3 2015 in Review

M&T Bank sold out of Anika Therapeutics (ANIK) in Q3 2015, closing a stake of 6,903 shares — an estimated $228K sold.

M&T Bank first reported a position in ANIK in Q3 2014 and held it in 4 quarters. The position peaked at $293K in Q4 2014. 138 funds tracked by Wall St. Rank hold ANIK as of Q3 2015.

  • M&T Bank reported no remaining Anika Therapeutics position as of Q3 2015 after selling out during the quarter.
  • M&T Bank sold 6,903 Anika Therapeutics shares in Q3 2015, an estimated $228K.
  • M&T Bank first reported a position in Anika Therapeutics in Q3 2014 and held it in 4 quarters.
  • M&T Bank's Anika Therapeutics position peaked at $293K in Q4 2014.
  • 138 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.